Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | 233.81% |
| Q3 2025 | 42.32% |
| Q2 2025 | 339.39% |
| Q1 2025 | 459.58% |
| Q4 2024 | 122.41% |
| Q3 2024 | 51.21% |
| Q2 2024 | 5.70% |
| Q1 2024 | -10.11% |
| Q4 2023 | 10.08% |
| Q3 2023 | -12.71% |
| Q2 2023 | -15.91% |
| Q1 2023 | -77.41% |
| Q4 2022 | 31.36% |
| Q3 2022 | -437.26% |
| Q2 2022 | -153.97% |
| Q1 2022 | -77.71% |
| Q4 2021 | -38.91% |
| Q3 2021 | -27.37% |
| Q2 2021 | -13.21% |
| Q1 2021 | 129.08% |
| Q4 2020 | -33.27% |
| Q3 2020 | -19.56% |
| Q2 2020 | -19.52% |
| Q1 2020 | 45.13% |
| Q4 2019 | -21.91% |
| Q3 2019 | -12.20% |
| Q2 2019 | -17.87% |
| Q1 2019 | -13.02% |
| Q4 2018 | 5.45% |
| Q3 2018 | -18.72% |
| Q2 2018 | 40.97% |
| Q1 2018 | -22.25% |
| Q4 2017 | 54.82% |
| Q3 2017 | -20.69% |
| Q2 2017 | -23.23% |
| Q1 2017 | 33.13% |
| Q4 2016 | -19.53% |
| Q3 2016 | -13.31% |
| Q2 2016 | -4.34% |
| Q1 2016 | -18.82% |